J Health Popul Nutr. 2025 Jan 18;44(1):14. doi: 10.1186/s41043-024-00727-9.
ABSTRACT
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory condition characterized by high morbidity and mortality rates. This study aims to assess the clinical outcomes of COPD patients after implementing an algorithm within the MyTatva app.
METHODS: The study involved a sample of 10 COPD patients, evaluating key parameters such as Forced Expiratory Volume in 1 s (FEV1), Forced Vital Capacity, Weight, Body Mass Index (BMI), Fat-Free Mass Index, and Distance Covered during the 6-Minute Walk Test (6MWT) before and after the algorithm's implementation in the MyTatva app. Patient satisfaction was assessed through a CSAT survey.
RESULTS: Following the implementation of the MyTatva care plan, significant improvements were observed in several key clinical outcomes for COPD patients. FEV1 increased from a median of 3.24-2.0 L (p = 0.0379), while weight and BMI decreased significantly, with a reduction in weight from a median of 86-70 kg (p = 0.0007) and a corresponding decrease in BMI from 28.43 to 24 kg/m2 (p = 0.0031). The distance covered during the 6MWT also improved from 420 to 568 m (p = 0.0019). The participation of 10 COPD patients in surveys yielded an overall CSAT score of 85%, indicating a high level of satisfaction with the MyTatva app.
CONCLUSION: The comprehensive features and functionalities of the MyTatva app, combined with the personalized care plan and real-time feedback mechanisms, have led to substantial clinical improvements in COPD management. These findings highlight the promise of this innovative digital therapeutic approach in addressing chronic respiratory conditions.
PMID:39827130 | PMC:PMC11743011 | DOI:10.1186/s41043-024-00727-9